Sands Capital Alternatives, LLC
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 13, 2025), Sands Capital Alternatives, LLC reported 21 stock positions worth $459.7 million. Its top holding was Klaviyo Class A (KVYO) at 31.1% of the portfolio, followed by Nu Holdings Ltd./Cayman Isl-A (NU, 15.8%) and DoorDash Class A (DASH, 14.9%). Compared with Q3 2024, it opened 2 new positions, sold out of 1, added to 7 and reduced 5. The biggest buy was a new position in Inhibikase Therapeutics (IKT) and the biggest sale Bioage Labs (BIOA, shares −28%).
- Most Recent 13F
- Q2 2026
- Location
- ARLINGTON, VA
- CIK
- 0001846444
- Portfolio Value
- $459.7M (Q4 2024)
- SEC Filing
- 0001020066-25-000015 ↗ filed Feb 13, 2025
Holdings Value
Holdings 21 stocks · $459.7M
| KVYO Klaviyo Inc. Class A | 31.13% | 3,470,694 | $143.1M | Reduce -1.3% |
| NU Nu Holdings Ltd./Cayman Isl-A filed as NU HLDGS LTD | 15.82% | 7,021,159 | $72.7M | Add +27.7% |
| DASH DoorDash Inc. Class A | 14.86% | 407,343 | $68.3M | Reduce -3.8% |
| IKT Inhibikase Therapeutics Inc. | 7.74% | 10,950,000 | $35.6M | New |
| CPNG Coupang Inc. | 4.42% | 924,712 | $20.3M | Add +7650.5% |
| PATH Uipath Inc. Class A | 4.38% | 1,584,677 | $20.1M | Add +37.2% |
| DDOG Datadog Inc. Class A | 3.04% | 97,788 | $14.0M | Add +6855.1% |
| ACRV Acrivon Therapeutics Inc. | 2.78% | 2,122,605 | $12.8M | No change |
| MNDY Monday.com Ltd. | 2.47% | 48,278 | $11.4M | New |
| TARS Tarsus Pharmaceuticals Inc. | 2.05% | 170,000 | $9.4M | No change |
| IOT Samsara Inc. Class A | 1.89% | 198,690 | $8.7M | Add +6163.9% |
| TOST Toast Inc. Class A | 1.84% | 231,530 | $8.4M | Add +5099.4% |
| TXG 10X Genomics Inc. Class A | 1.50% | 481,770 | $6.9M | No change |
| SNOW Snowflake Inc. | 1.31% | 39,007 | $6.0M | Reduce -64.0% |
| ABOS Acumen Pharmaceuticals Inc. | 1.28% | 3,417,075 | $5.9M | No change |
| CRWD CrowdStrike Holdings Inc. Class A | 1.27% | 17,100 | $5.9M | Add +7637.6% |
| BIOA Bioage Labs Inc. | 0.99% | 786,353 | $4.6M | Reduce -27.6% |
| CADL Candel Therapeutics Inc. | 0.77% | 405,837 | $3.5M | No change |
| TSHA Taysha Gene Therapies Inc. | 0.27% | 724,873 | $1.3M | No change |
| MASS 908 Devices Inc. | 0.11% | 237,258 | $522K | No change |
| SPRB Spruce Biosciences Inc. | 0.07% | 715,817 | $301K | Reduce -9.1% |
Portfolio Sells Q3 2024 → Q4 2024
Portfolio Buys Q3 2024 → Q4 2024
| IKT Inhibikase Therapeutics Inc. | New | 7.74% | +7.74 |
| CPNG Coupang Inc. | Add +7650.5% | 4.42% | +4.34 |
| DDOG Datadog Inc. Class A | Add +6855.1% | 3.04% | +2.99 |
| MNDY Monday.com Ltd. | New | 2.47% | +2.47 |
| IOT Samsara Inc. Class A | Add +6163.9% | 1.89% | +1.85 |
| TOST Toast Inc. Class A | Add +5099.4% | 1.84% | +1.80 |
| CRWD CrowdStrike Holdings Inc. Class A | Add +7637.6% | 1.27% | +1.26 |
| PATH Uipath Inc. Class A | Add +37.2% | 4.38% | +0.22 |
| NU Nu Holdings Ltd./Cayman Isl-A | Add +27.7% | 15.82% | −5.28 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 24 | $613.5M | ALMR, NU, KVYO, BBNX, SGP |
| Q1 2026 | 21 | $421.2M | NU, KVYO, SGP, BBNX, IKT |
| Q4 2025 | 20 | $518.5M | KVYO, NU, BBNX, IKT, DASH |
| Q3 2025 | 20 | $456.4M | NU, KVYO, BBNX, CPNG, DASH |
| Q2 2025 | 19 | $507.8M | KVYO, NU, DASH, BBNX, CPNG |
| Q1 2025 | 20 | $408.9M | KVYO, NU, DASH, BBNX, IKT |
| Q4 2024 | 21 | $459.7M | KVYO, NU, DASH, IKT, CPNG |
| Q3 2024 | 20 | $355.8M | KVYO, NU, DASH, BIOA, ACRV |
| Q2 2024 | 20 | $298.6M | NU, KVYO, DASH, PATH, SNOW |
| Q1 2024 | 20 | $414.7M | NU, KVYO, DASH, PATH, SNOW |